Author

Lynne I. Wagner

University of North Carolina at Chapel HillORCID 0000-0001-9685-4796Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Approach:experimental assay· 2 Research Focus:benchmarking· 1 Approach:statistical model· 1

Frequent Co-Authors

Angela R. BradburyiD· 3 shared Brian Lee EglestoniD· 3 shared Cara N. CacioppoiD· 3 shared Dominique FetzeriD· 3 shared Enida F. SelmaniiD· 3 shared Evelyn Mastaglio· 3 shared Janice Christiansen· 3 shared Kelsey KarpinkiD· 3 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersGenetic & Genomic Medicine

Angela R. BradburyORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Genetic & Genomic MedicineBMC CancerPeer-reviewedJul 31, 2026

Title: A Randomized Hybrid Type I Effectiveness-Implementation Study of an eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Cancer (eREACH2): study protocol

Evelyn Mastaglio, Brian Lee Egleston, Kimberley T. Lee…·Angela R. Bradbury

The eREACH2 study evaluates a digital intervention for cancer genetic testing compared to traditional counseling, aiming to improve access and outcomes for at-risk patients.

2 citationstop 2%

humanexperimental assay

𝕏 PostBluesky

Genetic & Genomic MedicineJournal of Clinical OncologyPeer-reviewedMay 27, 2026

A Randomized Non-Inferiority Trial of an eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Cancer (eREACH2)

Kimberley T. Lee, Brian Lee Egleston, Dominique Fetzer…·eREACH2 Group

eREACH2 evaluates a digital alternative to genetic counseling for cancer genetic testing, finding it non-inferior for service uptake and anxiety but inconclusive for knowledge, with mixed outcomes for result disclosure.

DOI 10.1200/jco.2026.44.16_suppl.10510

humanstatistical model

𝕏 PostBluesky

Genetic & Genomic MedicinemedRxivPreprintOct 1, 2025

eREACH: A randomized trial of digital alternatives to genetic counseling for metastatic cancer

Kimberley T. Lee, Brian Lee Egleston, Briana I. McLeod…·Angela R. Bradbury

eREACH evaluates digital alternatives to genetic counseling for metastatic cancer patients, finding non-inferiority in short-term outcomes for one GC visit or fully digital models.

3 citations

humanexperimental assay

𝕏 PostBluesky